معرفی
Markus Sjöblom is a Senior Lecturer at Uppsala University's Department of Medical Cell Biology within the Faculty of Medicine. He holds a PhD and Associate Professor qualifications, with research primarily focused on gastrointestinal physiology and drug effects on intestinal function. His work spans molecular mechanisms of mucosal barrier function, duodenal bicarbonate secretion, and chemotherapy-induced intestinal damage.
Dr. Sjöblom's research interests center on gastrointestinal physiology, particularly intestinal mucosal barrier function and duodenal bicarbonate secretion. His work investigates how various drugs, including melatonin, affect intestinal permeability and protect against chemotherapy-induced damage. He has made significant contributions to understanding the physiological mechanisms behind drug absorption and intestinal toxicity, with applications for improving cancer treatment side effects.
His recent publications demonstrate a clear research trajectory focusing on chemotherapy-induced mucositis, intestinal permeability changes, and protective mechanisms. The work spans from basic physiological investigations of duodenal function to translational studies examining drug effects in rat models and developing therapeutic approaches for gastrointestinal side effects of cancer treatments. Much of his recent work focuses on melatonin's protective effects against chemotherapy-induced intestinal damage.
- Accepted as an excellent teacher at the scientific domain of medicine and pharmacy in 2020
Dr. Sjöblom leads his own research group (21.6.6 Research group Markus Sjöblom) within the Department of Medical Cell Biology. His work receives substantial attention, with multiple publications highlighted across academic platforms and referenced in patents. His research on intestinal physiology has established important connections between mucosal barrier function, drug absorption, and chemotherapy side effects, contributing significantly to gastrointestinal pharmacology.
